Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity E.m.ld Regulatory News (FEML)

Share Price Information for Fidelity E.m.ld (FEML)

Share Price is delayed by 15 minutes
Get Live Data
1,400.00    -12.00 (-0.85%)
Bid:
1,398.00
Ask:
1,404.00
Spread: 6.00 (0.429%)
Market Cap: £565.34m
FEML Live PriceLast checked at - London Stock Exchange

Intraday Fidelity E.m.ld Share Chart

Net Asset Value(s)

17 Dec 2025 07:52

RNS Number : 9193L
Fidelity Emerging Markets Limited
17 December 2025
 
Fidelity Emerging Markets Limited 
17 December 2025 
  
The Directors of Fidelity Emerging Markets Limited announce the following unaudited estimates as at 16 December 2025:
  
NAV (ex income)
1082.77p
NAV (cum income)
1094.80p
Total Assets (ex income)
£485.330 million
Total Assets (cum income)
£490.723 million
  
  
Enquiries:  
  
Fidelity Investment International 
Phone + 44 ( 0) 1737 837846 
  
END  
  
Fidelity Emerging Markets Limited 
Source: Fidelity Emerging Markets Limited 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDDLBFELLEFBF
Date   Source Headline
1st Dec 20252:21 pmPRNTotal Voting Rights
1st Dec 20251:46 pmPRNResult of AGM
1st Dec 20257:59 amRNSNet Asset Value(s)
28th Nov 20255:02 pmPRNTransaction in Own Shares
28th Nov 20258:24 amRNSNet Asset Value(s)
27th Nov 20257:52 amRNSNet Asset Value(s)
26th Nov 20255:11 pmPRNTransaction in Own Shares
26th Nov 20257:55 amRNSNet Asset Value(s)
25th Nov 20255:35 pmPRNTransaction in Own Shares
25th Nov 20253:20 pmPRNMonthly Factsheet
25th Nov 20257:59 amRNSNet Asset Value(s)
24th Nov 20258:01 amRNSNet Asset Value(s)
21st Nov 20255:28 pmPRNTransaction in Own Shares
21st Nov 20257:56 amRNSNet Asset Value(s)
20th Nov 20255:13 pmPRNTransaction in Own Shares
20th Nov 20254:26 pmPRNHolding(s) in Company
20th Nov 20257:45 amRNSNet Asset Value(s)
19th Nov 20255:21 pmPRNTransaction in Own Shares
19th Nov 202511:12 amPRNNon-Executive Director Declaration
19th Nov 20257:48 amRNSNet Asset Value(s)
18th Nov 20255:29 pmPRNTransaction in Own Shares
18th Nov 20257:45 amRNSNet Asset Value(s)
17th Nov 20255:40 pmPRNTransaction in Own Shares
17th Nov 20257:57 amRNSNet Asset Value(s)
14th Nov 20255:42 pmPRNTransaction in Own Shares
14th Nov 20253:54 pmPRNHolding(s) in Company
14th Nov 202511:01 amPRNFinal Dividend Exchange Rate
14th Nov 20257:57 amRNSNet Asset Value(s)
13th Nov 20255:05 pmPRNTransaction in Own Shares
13th Nov 20258:02 amRNSNet Asset Value(s)
12th Nov 20255:20 pmPRNTransaction in Own Shares
12th Nov 202512:48 pmPRNTransaction in Own Shares
12th Nov 20257:36 amRNSNet Asset Value(s)
11th Nov 20257:40 amRNSNet Asset Value(s)
11th Nov 20257:00 amRNS-RKepler Trust Intelligence: New Research
10th Nov 20257:31 amRNSNet Asset Value(s)
7th Nov 20257:53 amRNSNet Asset Value(s)
6th Nov 20257:56 amRNSNet Asset Value(s)
5th Nov 20252:18 pmPRNCancellation of Treasury Shares
5th Nov 20257:42 amRNSNet Asset Value(s)
4th Nov 20257:31 amRNSNet Asset Value(s)
3rd Nov 20254:04 pmPRNTotal Voting Rights
3rd Nov 20257:50 amRNSNet Asset Value(s)
31st Oct 20258:00 amRNSNet Asset Value(s)
30th Oct 20257:46 amRNSNet Asset Value(s)
29th Oct 202510:15 amPRNRepurchase Timetable
29th Oct 20257:39 amRNSNet Asset Value(s)
28th Oct 20257:32 amRNSNet Asset Value(s)
27th Oct 20257:56 amRNSNet Asset Value(s)
24th Oct 202512:29 pmPRNResult of Extraordinary General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.